IVD products analyzers (MQ60 series, UPT2800) and reagents

IVD products analyzers (MQ60 series, UPT2800) and reagents

Devices
IVD products analyzers (MQ60 series, UPT2800) and reagents
IVD products analyzers (MQ60 series, UPT2800) and reagents
IVD products analyzers (MQ60 series, UPT2800) and reagents

Information

MQ60 mono-test chemiluminescence series – designed for direct whole-blood testing, delivering results in 10 minutes with single-use packaging, perfectly suited for emergency and primary care; C800 compact fully automated chemiluminescence immunoassay analyzer – offering efficient and cost-effective testing for small and medium-sized laboratories; UPT2800 up-converting phosphor technology immunoassay analyzer – recognized for its high sensitivity and ease of use; TB-IGRA (Interferon-Gamma Release Assay for Tuberculosis infection) and TB PCR POCT (Rapid Molecular Detection for TB) were showcased as key highlights, providing fast, accurate, and sensitive solutions for tuberculosis screening and diagnosis in Africa; Additionally, colloidal gold rapid tests and ELISA kits formed part of Hotgen’s diverse diagnostic ecosystem, adaptable to multiple clinical scenarios.
Sub-Categories Offered
Point of Care Testing Device
Beijing Hotgen Biotech Co., Ltd.H5.C59Beijing Hotgen Biotech Co., Ltd. (“Hotgen Biotech”), founded in 2005, is a high-tech enterprise specializing in the biopharmaceutical field. The company was listed on the STAR Market of the Shanghai Stock Exchange in September 2019 (Stock Code: 688068). Hotgen Biotech has established eight major technology platforms, including bioactive raw material development, GlyExo-Capture®, chemiluminescence immunoassay, up-converting phosphor technology, colloidal gold immunochromatography, Enzyme-Linked ImmunoSorbent Assay, molecular diagnostics, and instrument development. Our product portfolio spans the full spectrum of immunodiagnostics — from high-precision Up-Conversion POCT (UPT series) to compact, mid-sized, and fully automated single-test chemiluminescence analyzers (MQ60 series), and high-throughput automated chemiluminescence platforms (C800). Hotgen Biotech’s products have obtained certificates and registrations from major regulatory authorities worldwide, with over 600 international qualifications to date — among them, more than 90 CE IVDR certificates. we are committed to providing better services to our global customers and continuously expanding our international presence.